Vlastarakos Petros V, Nikolopoulos Thomas P, Tavoulari Evangelia, Papacharalambous George, Korres Stavros
ENT Department, Hippokrateion General Hospital of Athens, 114 Vas. Sofias Avenue, Athens, 11527, Athens, Greece.
Int J Pediatr Otorhinolaryngol. 2008 Aug;72(8):1135-50. doi: 10.1016/j.ijporl.2008.04.004. Epub 2008 May 27.
BACKGROUND/OBJECTIVE: Auditory neuropathy/dys-synchrony, characterized by absent auditory brainstem responses, normal otoacoustic emissions or cochlear microphonics, and word discrimination disproportional to the pure-tone audiogram, may be accompanied by perceptual consequences that could jeopardize language acquisition in affected children. However, the related evidence is constantly changing leading to a serious debate. The aim of the present paper is to review the current knowledge on auditory neuropathy/dys-synchrony, and to present the therapeutic strategies that can be employed in its management, taking into account the potentially underlying pathophysiology.
MATERIALS/METHODS: Literature review from Medline and database sources. Related books were also included.
Controlled clinical trials, prospective and retrospective cohort studies, nested-based case-control and analytical family studies, laboratory and electrophysiological studies, animal models, case-reports, joint statements and review articles.
Auditory neuropathy/dys-synchrony, in contrast to what is widely believed, is a very frequent disease, responsible for approximately 8% of newly diagnosed cases of hearing loss in children per year. Hyperbilirubinemia and hypoxia represent major risk factors, whereas generalized neuropathic disorders, or a genetic substrate involving the otoferlin gene, are responsible for the phenotype of auditory neuropathy/dys-synchrony in certain cases. Auditory nerve myelinopathy and/or desynchrony of neural discharges are the most probable underlying pathophysiologic mechanisms. Genetic testing may be helpful in cases of non-syndromic prelingual children. Auditory neuropathy/dys-synchrony management aims at restoring the compromised processing of auditory information, either through conventional amplification and/or alternative forms of communication, or by cochlear implantation (combined with intensive speech and language therapy).
Auditory neuropathy/dys-synchrony is more frequent than considered in the past, especially amongst hearing-impaired children. Accurate diagnosis, based on subjective and objective hearing assessment techniques (including the various electrophysiological assessment measures), and timely treatment of the affected children is of paramount importance, with hearing aids, intensive speech and language therapy (and sign language when indicated) providing the mainstay of habilitation, and cochlear implantation representing a valid therapeutic alternative.
背景/目的:听神经病/失同步表现为听觉脑干反应消失、耳声发射或耳蜗微音电位正常,以及言语辨别能力与纯音听力图不成比例,可能伴有一些感知后果,这些后果可能会危及受影响儿童的语言习得。然而,相关证据不断变化,引发了激烈的争论。本文旨在回顾当前关于听神经病/失同步的知识,并考虑其潜在的病理生理学,提出可用于其管理的治疗策略。
材料/方法:从Medline和数据库来源进行文献综述。相关书籍也被纳入。
对照临床试验、前瞻性和回顾性队列研究、巢式病例对照和分析性家族研究、实验室和电生理研究、动物模型、病例报告、联合声明和综述文章。
与广泛认为的情况相反,听神经病/失同步是一种非常常见的疾病,每年约占新诊断儿童听力损失病例的8%。高胆红素血症和缺氧是主要危险因素,而在某些情况下,全身性神经病变或涉及 otoferlin 基因的遗传底物是听神经病/失同步表型的原因。听神经髓鞘病和/或神经放电不同步是最可能的潜在病理生理机制。基因检测对非综合征性语前儿童病例可能有帮助。听神经病/失同步的管理旨在通过传统放大和/或其他形式的交流,或通过人工耳蜗植入(结合强化言语和语言治疗)来恢复受损的听觉信息处理。
听神经病/失同步比过去认为的更为常见,尤其是在听力受损儿童中。基于主观和客观听力评估技术(包括各种电生理评估措施)进行准确诊断,并及时治疗受影响儿童至关重要,助听器、强化言语和语言治疗(以及必要时的手语)是康复的主要手段,人工耳蜗植入是一种有效的治疗选择。